review of pharm 1 Flashcards

1
Q

biotechnology

A

manipulating DNA or RNA. example covid vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

brand name

A

example purrell (hand sanitizer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pharmacodynamics

A

drug action on the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pharmacogenetics

A

changes in drugs effectiveness related to genetic heritage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pharmacokinetics

A

movement of a drug throughout the body, how its metabolized, absorbed…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pharmacotherapy

A

treatment using drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

first pass effect

A

initial metabolism of oral medications (pass through liver before it gets to systemic effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

loading dose/ bolos

A

larger than regular dose, given once before maintenance dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

serum half life

A

time required for the drug concentration to decrease by 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

enteric coated

A

makes drug insoluble to stomach acid/ do not crush

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

controlled release

A

slow release, maintain consistent serum level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

enteral

A

NG tubes, PEG tubes (tube feeding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

parenteral

A

IV (TPN), anything enters the vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pre-clinical phase

A

testing out on animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

clinical phase 1

A

trial on healthy volunteers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

clinical phase 2

A

people that have the disease or symptoms

17
Q

clinical phase 3

A

given to random people, large population, adverse effects, benefits out way risk

18
Q

clinical phase 4

A

continue to monitor, given to more

19
Q

QSEN

A

patient centered care, EBP, safety, informatics, quality improvement, teamwork and collaboration

20
Q

the nurse knows that controlled drugs are

A

scheduled according to potential for abuse: the FDA assigns a drugs schedule based on medical use and its abuse potential. Higher numbers= less potential for abuse

21
Q

a pt has tube feeding running at 10 ml/ hr and IV normal saline running at 50 ml/ hr. what is the pt parenteral intake after 4 hours ?

A

200 ml

22
Q

absorption

A

how fast the drug reaches the target cells

23
Q

distribution

A

blood stream to the cells, more to do with blood flow

24
Q

metabolism

A

how is the drug inactivated, liver is most common, P450

25
Q

excretion

A

eliminating drug from the system, kidneys is most common

26
Q

cross tolerance

A

one drug leads to needing an increase of another drug

27
Q

type 1 drug allergy

A

anaphylactic reactions

28
Q

type 2 drug allergy

A

cytotoxic reaction (blood incompatibility)

29
Q

type 3 drug allergy

A

serum sickness (immune)

30
Q

type 4 drug allergy

A

delayed reaction (rash, poison ivy)

31
Q

a pt with an overdose of an unknown oral drug usually receives which of the following

A

activated charcoal “universal antidote”

32
Q

most common medication mistake

A

calculations

33
Q

beers criteria

A

looks for medications that may be inappropriate for older adults

34
Q

older adult pharmacodymancis

A

reduced receptor site, medication tolerance, chronic illness, polypharmacy, beers criteria

35
Q

older adult pharmacokinetics: absorption

A

increased gastric pH, delayed gastric emptying, decreased blood flow

36
Q

older adult pharmacokinetics: metabolism

A

decreased hepatic mass and blood flow

37
Q

older adult pharmacokinetics: distribution

A

increased body fat, decreased total body water, decreased serum albumin

38
Q

older adult pharmacokinetics: elimination

A

decreased creatinine Clarence, decreased GFR, decreased tubular filtration